Picture of Symrise AG logo

SY1 — Symrise AG News Story

0.000.00%
de flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapHigh Flyer

Germany's Symrise Q3 organic sales rise 5.3% on higher volumes

Germany's Symrise Q3 organic sales rise 5.3% on higher volumes


Overview

  • Germany flavors and fragrances supplier's Q3 organic sales grew 5.3%, group sales rose yr/yr

  • Company repurchased 4.3 mln shares as part of ongoing buyback program

  • Company reaffirmed full-year 2026 outlook for organic sales growth and EBITDA margin


Outlook

  • Symrise reaffirms 2026 organic sales growth guidance of 2% to 4%

  • Company expects 2026 adjusted EBITDA margin of 21.5% to 22.5%

  • Company expects Q4 sales growth to moderate sequentially from Q3 due to tougher comparables


Result Drivers

  • VOLUME-DRIVEN GROWTH - Co said Q3 sales growth was mainly driven by higher volumes, supported by solid customer demand and favorable year-on-year comparables

  • REGIONAL MOMENTUM - Double-digit growth in Asia Pacific and strong growth in Latin America contributed to overall sales performance

  • SEGMENT PERFORMANCE - Food & Beverage, Naturals, and Aroma Molecules divisions saw notable organic sales growth


Company press release: ID:nEQ4RPK5Qa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

9M Revenue

EUR 3.85 bln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Symrise AG is €100.00, about 0% below its October 27 closing price of €100.05

  • The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • Oct 28 - Germany's BASF raises core profit outlook again after quarterly beat

  • Oct 27 - Beiersdorf Q3 sales slightly miss expectations as Nivea weakness persists

  • Oct 26 - France's MEMSCAP Q3 revenue rises on medical and aerospace strength


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Symrise AG

See all news